10.03.2018 | Letter to the Editor (by invitation)
Reply to the letter to the editor: Aflibercept in diabetic macular edema refractory to previous bevacizumab: outcomes and predictors of success
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 7/2018
Einloggen, um Zugang zu erhalten